Clinical recognition of cardiac hypertrophy
Burchell, H.B.
Circulation Research 35(2) Suppl Ii: 116-21
1974
ISSN/ISBN: 0009-7330 PMID: 4276495 Document Number: 78362
Document emailed within 1 workday
Related Documents
Widimský, J. 1993: Cardiac hypertrophy in hypertension--clinical significance and possibilities of control Cor et Vasa 35(2): 84-89Robberecht, P.; Waelbroeck, M.; Claeys, M.; Huu, A.N.; Chatelain, P.; Christophe, J. 1982: Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy Molecular Pharmacology 21(3): 589-593
Pagano, V.T.; Inchiosa, M.A. 1979: Characterization of the decreased ATPase activity of rat cardiac actomyosin in isoproterenol-induced cardiac hypertrophy Research Communications in Chemical Pathology and Pharmacology 23(1): 37-47
Smirnov, I.E.; Fatkhullin, I.A.; Markov, K.M. 1990: Production of cardiac prostanoids and the fatty acid composition of cardiac phospholipids in various types of myocardial hypertrophy Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 6: 10-13
Pummerer, C.L.; Grässl, G.; Sailer, M.; Bachmaier, K.W.; Penninger, J.M.; Neu, N. 1996: Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells Laboratory Investigation; A Journal of Technical Methods and Pathology 74(5): 845-852
Lêger, J.J.; Schwartz, K.; Swynghedauw, B. 1977: Myosin and cardiac hypertrophy Pathologie-Biologie 25(2): 75-80
Hayashida, W.; Kihara, Y.; Sasayama, S. 2000: Cardiac hypertrophy associated with hypertension: its management Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl 2): 305-308
Yorikane, R.; Sakai, S.; Miyauchi, T.; Sakurai, T.; Goto, K. 1994: Possible involvement of endothelin-1 in cardiac hypertrophy Arzneimittel-Forschung 44(3a): 412-415
Morkin, E. 1974: Activation of synthetic processes in cardiac hypertrophy Circulation Research 35(2): Suppl Ii: 37-48
Bertrand, E.; Bile, A.; Ekra, A.; Touze, J.E.; Le Gallais, D. 1987: Cardiac hypertrophy, dilatation and performance in top athletes Annales de Cardiologie et d'Angeiologie 36(2): 63-68
Rossi, G.; Cecchi, F. 1995: Genetics and molecular biology of cardiac hypertrophy Giornale Italiano di Cardiologia 25(12): 1643-1648
Xu, X.-d.; Song, X.-w.; Jing, Q.; Qin, Y.-w. 2011: Effect of miRNA-199a on rat cardiac hypertrophy Zhonghua Xin Xue Guan Bing Za Zhi 39(5): 446-450
Parker, T.G. 1993: Molecular biology of cardiac growth and hypertrophy Herz 18(4): 245-255
Ishikawa, Y. 2004: High blood pressure and cardiac hypertrophy Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl. 3: 342-346
López-Beltrán, A.; Sáez, J.; Lachica, E. 1997: Lipomatous hypertrophy of the cardiac interatrial septum American Journal of Forensic Medicine and Pathology 18(2): 206-207
Caceres, C.A. 1970: Computer recognition of cardiac arrhythmias Cardiovascular Clinics 2(2): 295-306
Hradec, J.; Marek, J.; Petrásek, J. 1988: The nature of cardiac hypertrophy in acromegaly: an echocardiographic study Cor et Vasa 30(3): 186-199
Tagawa, H.; Wang, N.; Narishige, T.; Ingber, D.E.; Zile, M.R.; Cooper, G.; Zile, M.R. 1997: Cytoskeletal mechanics in pressure-overload cardiac hypertrophy Circulation Research 80(2): 281-289
Büchner, F. 1972: Moderation and excess as illustrated on the example of cardiac hypertrophy and insufficiency Wiener Klinische Wochenschrift 84(6): 89-92
Neri Serneri, G.G.; Modesti, P.A.; Boddi, M. 1997: The cardiac autocrine-paracrine system in the development of hypertrophy Cardiologia 42(1): 11-19